Leo's oral vitamin D analogue induces regression, inhibits tumor growth in hepatocellular carcinoma Nov. 13, 1998 No Comments
Favorable phase III trial results presented for Evacet at ESMO; company prepares NDA Nov. 12, 1998 No Comments
Small-molecule FGFR-1 tyrosine kinase inhibitor with nanomolar potency and good selectivity Nov. 12, 1998 No Comments
New anticancer drug candidate revealed by Sugen; product enters phase I testing in U.K. Nov. 11, 1998 No Comments